Asbestos

Dail and Hammar's Pulmonary Pathology

Volumn 1, Issue , 2008, Pages 950-1031

  Hammar, Samuel P ^a   Dodson, Ronald F ^b  

^a Harrison Medical Center   (United States)

^b ERI Consulting Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77749247116     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68792-6_27     Document Type: Chapter

References (469)

1. Webster's medical dictionary. Springfield, MA: MerriamWebster, 1986:51.
2. Weill H, Abraham JL, Balmes JR, et al. Health effects of tremolite. Am Rev Respir Dis 1990;142:1453-1458.
3. Occupational exposure to asbestos, tremolite, anthophyllite and actinolite: final rule. Department of Labor. Fed Reg 1992;57(110):24310-24331.
4. Henderson DW, Shilkin KB, Whitaker D. Introduction and historical aspects, with comments on mesothelioma registries. In: Henderson DW, Shilkin KB, Langlois SL, Whitaker D, eds. Malignant mesothelioma. New York: Hemisphere, 1992: 1-22.
5. Pooley FD. Asbestos mineralogy. In: Antman K, Aisner J, eds. Asbestos-related malignancy. Orlando: Grune & Stratton, 1987:327.
6. Teta MJ, Lewinsohn HC, Meigs JW, Vidone RA, Mowad LZ, Flannery JT. Mesothelioma in Connecticut, 1955-1977. J Occup Med 1983;25:749-756.
7. Dodson RF, Levin JL. An unusual case of mixed-dust exposure involving a "non-commercial" asbestos. Environ Health Perspect 2001;109:199-203.
8. Churg A, Wright JL, Vedal S. Fiber burden and patterns of asbestos-related disease in chrysotile miners and millers. Am Rev Resp Dis 1993;148:25-31.
9. Marchand F. Uber eigentumliche pigmentkristalle in den lungen. Verh Dtsch Ges Pat hoI 1906;17:223-228.
10. Cooke WE. Asbestos dust and the curious bodies found in pulmonary asbestosis. Br Med J 1929;2:578-580.
11. Gloyne SR. The formation of the asbestos body in the lung. Tubercle 1931;12:399-401.
12. Craighead JE, Abraham JL, Churg A, et al. Asbestos-associated diseases. Arch Pathol Lab Med 1982;106:542-596.
13. Barclay WR, Craighead JE, Cugell DW, et al. A physician's guide to asbestos-related diseases. JAMA 1984;252:2593-2597.
14. Gross P, deTreville RTP, Cralley LJ, Davis JMG. Pulmonary ferruginous bodies. Arch Pathol 1968;85:539-546.
15. Gross P, Tuma J, deTreville RTP. Unusual ferruginous bodies. Arch Environ Health 1971;22:534-537.
16. Timbrell V. The inhalation of fibrous dusts. Ann NY Acad Sci 1965;132:255-273.
17. Dodson RF, Williams MG, Hurst GA. Acute lung response to amosite asbestos: a morphological study. Environ Res 1983;32:80-90.
18. Davis JMG. Further observations on the ultrastructure and chemistry of the formation of asbestos bodies. Exp Mol Pathol 1970;13:346-358.
19. Suzuki Y. Interaction of asbestos with alveolar cells. Environ Health Perspect 1974;9:241-252.
20. Brody AR, Hill LH, Adkins B, O'Connor RW. Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1981;123:670-679.
21. Davis JMG. Electron microscope studies of asbestosis in man and animals. Ann NY Acad Sci 1965;132:98-111.
22. Suzuki Y, Churg 1. Structure and development of the asbestos body. Am J PathoI1969;55:79-107.
23. Pooley FD. Asbestos bodies, their formation, composition and character. Environ Res 1972;5:363-379.
24. Botham SK, Holt PF. The mechanism of formation of asbestos bodies. J Pathol BacterioI1968;96:443-453.
25. Davis JMG. The ultrastructure of asbestos bodies from human lung. Br J Exp Pathol 1964;45:642.
26. Holt PF, Mills J, Young DK. Experimental asbestosis in the guinea pig. J Pathol BacterioI1966;92:185-195.
27. Davis JMG. The ultrastructure of asbestos from guinea pig lungs. Br J Exp Pathol 1964;45:634.
28. Godwin MC, Jagatic JJ. Asbestos and mesotheliomas. Environ Res 1970;3:391-416.
29. Holmes A, Morgan A, Davison W. Formation of pseudoasbestos bodies on sized glass fibres in the hamster lung. Ann Occup Hyg 1983;27:301-313.
30. Churg A, Warnock ML. Analysis of the cores of ferruginous (asbestos) bodies from the general population. III. Patients with environmental exposure. Lab Invest 1979;40: 622-626.
31. Churg A, Warnock ML. Analysis of the cores of ferruginous (asbestos) bodies from the general population. 1. Patients with and without lung cancer. Lab Invest 1977; 37:280-286.
32. Churg A, Warnock ML. Asbestos and other ferruginous bodies. Am J Pathol 1981;102:447-456.
33. Langer AM, Rubin IE, Selikoff IJ. Chemical characterization of asbestos body cores by electron microprobe analysis. J Histochem Cytochem 1972;20:723-734.
34. Gross P, deTreville RTP. Pulmonary ferruginous bodies in city dwellers. Arch Environ Health 1969;19:186-188.
35. Churg A, Warnock ML. Analysis of the cores of asbestos bodies from members of the general population: patients with probable low-degree exposure to asbestos. Am Rev Respir Dis 1979;120:781-786.
36. Dodson RF, O'Sullivan MF, Williams MG, Hurst GA. Analysis of cores of ferruginous bodies from former asbestos workers. Environ Res 1982;28:171-178.
37. Warnock ML, Isenberg W. Asbestos burden and the pathology of lung cancer. Chest 1986;89:20-26.
38. Holden J, Churg A. Asbestos bodies and the diagnosis of asbestosis in chrysotile workers. Environ Res 1986;39: 232-236.
39. Roggli VL, Pratt Pc. Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests. Hum Pathol 1983;14:355-361.
40. Andrion A, Bellis D, Bertoldo E, et al. Coated and uncoated mineral fibers in subjects with and without pleural plaques at autopsy. Pathol Res Pract 1984;178:611-615.
41. Warnock ML, Wolery G. Asbestos bodies or fibers and the diagnosis of asbestosis. Environ Res 1987;44:29-44.
42. Dodson RF, Williams MG, O'Sullivan MF, Corn CJ, Greenberg SD, Hurst GA. A comparison of the ferruginous body and uncoated fiber content in the lungs of former asbestos workers. Am Rev Respir Dis 1985;132:143-147.
43. Churg A, Warnock ML, Green N. Analysis of the cores of ferruginous (asbestos) bodies from the general population. Lab Invest 1979;40:31-38.
44. Mueller PK, Stanley RL. Asbestos fiber atlas. Washington, DC: U.S. Environmental Protection Agency, 1975:919.
45. Hendry NW. The geology occurrences and major uses of asbestos. In: Boland B, ed. Annals of the New York Academy of Sciences, 132nd ed. New York: New York Academy of Sciences, 1965:12.
46. Clifton RA. Asbestos. In: Bureau of Mines, ed. Bureau of Mines mineral yearbook. Washington, DC: U.S. Department of the Interior, 1973:15.
47. Wagner Jc. The significance of asbestos in tissue. Recent Results Cancer Res 1972;39:37-46.
48. Levin JL, O'Sullivan MF, Corn CJ, Williams MG, Dodson RF. Asbestosis and small cell lung cancer in a clutch refabrica tor. Occup Environ Med 1999;56:602-605.
49. Dodson RF, Williams MG, Hurst GA. Method for removing the ferruginous coating from asbestos bodies. J Toxicol Environ Health 1983;11:959-966.
50. Telischi M, Rubenstone AL. Pulmonary asbestosis. Arch PathoI1961;72:116-125.
51. Langer AM. Inorganic particles in human tissues and their association with neoplastic disease. Environ Health Perspect 1974;9:229-233.
52. Auerbach O, Conston AS, Garfinkel L, Parks VR, Kaslow HD, Hammond EC. Presence of asbestos bodies in organs other than the lung. Chest 1980;77:133-137.
53. Keal EE. Asbestosis and abdominal neoplasms. Lancet 1960;2:1211-1216.
54. Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes and pleural plaques from former shipyard workers. Am Rev Respir Dis 1990;142:843-847.
55. Roggli VL, Benning TL. Asbestos bodies in pulmonary hilar lymph nodes. Mod PathoI1990;3:513-517.
56. Szendroi M, Nemeth L, Vajta G. Asbestos bodies in a bile duct cancer after occupational exposure. Environ Res 1983;30:270-280.
57. Rosen P, Gordon P, Savino A, Melamed M. Ferruginous bodies in benign fibrous pleural plaques. Am J Clin Pathol 1973;60:608-617.
58. Kobayashi H, Ming ZW, Watanabe H, Ohnishi Y. A quantitative study on the distribution of asbestos bodies in extrapulmonary organs. Acta Pathol Jpn 1987;37:375-383.
59. Kanazawa K, Birbeck MSC, Carter RL, Roe FJC. Migration of asbestos fibres from subcutaneous injection sites in mice. Br J Cancer 1970;24:96-106.
60. Koerten HK, de Bruijn JD, Daems WT. The formation of asbestos bodies by mouse peritoneal macrophages. Am J Pathol 1990;137:121-134.
61. Williams MG, Dodson RF, Dickson EW, Fraire AE. An assessment of asbestos body formation in extrapulmonary sites: liver and spleen. Toxicol Ind Health 2001;17:1-6.
62. Cook PM, Glass GE, Tucker JH. Asbestiform amphibole minerals: detection and measurement of high concentrations in municipal water supplies. Science 1974;185:853-855.
63. Millette JR, Clark PJ, Stober J, Rosenthal M. Asbestos in water supplies of the United States. Environ Health Perspect 1983;53:45-48.
64. Cotruvo JA. Asbestos in drinking water: a status report. Environ Health Perspect 1983;53:181-183.
65. Toft P, Meek ME. Asbestos in drinking water: a Canadian view. Environ Health Perspect 1983;53:177-180.
66. Biles B, Emerson TR Examination of fibers in beer. Nature (London) 1968;219:93-94.
67. Gaudichet A, Bientz M, Sebastien P, et al. Asbestos fibers in wines: relation to filtration process. J Toxicol Environ Health 1978;4:853-860.
68. Selikoff 11, Lee DHK. Historical background. In: Lee DHK, Hewson EW, Okun D, eds. Asbestos and disease. New York: Academic Press, 1978:3-8.
69. Dodson RF, Huang J, Bruce JR Asbestos content in lymph nodes of nonoccupationally exposed individuals. Am J Ind Med 2000;37:169-174.
70. Dodson RF, Graef R, Shepherd S, O'Sullivan M, Levin 1. Asbestos burden in cases of mesothelioma from Individuals from various regions of the United States. J Ultrastruct Pathol 2005;29:415-433.
71. Churg A The diagnosis of asbestosis. Hum PathoI1989;20: 97-99.
72. Williams E. "Curious bodies" found in the lungs of coalworkers. Lancet 1934;2:541-542.
73. Masse S, Begin R, Cantin A Pathology of silicon carbide pneumoconiosis. Mod Pathol 1988;1:104-108.
74. Dodson RF, O'Sullivan MF, Corn C, Williams MG, Hurst GA. Ferruginous body formation on a nonasbestos mineral. Arch Pathol Lab Med 1985;109:849-852.
75. Churg A, Wiggs B. Mineral particles, mineral fibers, and lung cancer. Environ Res 1985;37:364-372.
76. Churg A Asbestos fiber content of the lungs in patients with and without asbestos airways disease. Am Rev Respir Dis 1983;127:470-473.
77. Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. Non-asbestos fibre burden in individuals exposed to asbestos. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 29-37.
78. Omenn GS, Merchant J, Boatman E, et al. Contribution of environmental fibers to respiratory cancer. Environ Health Perspect 1986;70:51-56.
79. Langer AM. Chrysotile asbestos in the lungs of persons in New York City. Arch Environ Health 1971;22:348-361.
80. Langer AM, Pooley FD. Identification of single asbestos fibres in human tissues. In: Biological effects of asbestos. Lyon: International Agency for Research on Cancer, 1973:119125.
81. Dodson RF, Williams MG, Corn CJ, Brollo A, Bianchi C. A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann NY Acad Sci 1991;643: 53-60.
82. Dodson RF, O'Sullivan M, Hammar SP. Quality control analysis of the potential for asbestos contamination during tissue process in pathology laboratories. Arch Pathol Lab Med 2004;128:781-784.
83. Upton AC, Barrett MR, Burdett G, et al. Health Effects Institute-Asbestos Research: asbestos in public and commercial buildings: a literature review and synthesis of current knowledge. [Anonymous] Cambridge: Health Effects Institute 1991.
84. Champness PE, Cliff G, Lorimer Gw. The identification of asbestos. J Microsc 1976;108:231-249.
85. Millette JR, Twyman JD, Hansen EC, Clark PJ, Pansing MF. Chrysotile, palygorskite, and halloysite in drinking water. Scand Electron Microsc 1979;1:579-586.
86. Berkley C, Churg J, Selikoff IJ, Smith WE. The detection and localization of mineral fibers in tissue. In: Boland B, Hitchcock J, Kates S, eds. Biological effects of asbestos, 132nd ed. New York: New York Academy of Sciences, 1965:4863.
87. Carter RE, Taylor WF. Identification of a particular amphibole asbestos fiber in tissue of persons exposed to a high oral intake of the mineral. Environ Res 1980;24:85-93.
88. Pooley FD. Electron microscope characteristics of inhaled chrysotile asbestos fibers. Br J Ind Med 1972;29:146-153.
89. Chatfield E1. Preparation and analysis of particulate samples by electron microscopy, with special reference to asbestos. Scanning Electron Microsc 1979;1:563-578.
90. Chatfield EJ, Dillon M1. Some aspects of specimen preparation and limitations of precision in particulate analysis by SEM and TEM. Scanning Electron Microsc 1978;1: 487-496.
91. Ashcroft T, Heppleston AG. The optical and electron microscopic determination of pulmonary asbestos fiber concentration and its relation to the human pathological reaction. J Clin Pathol 1973;26:224-234.
92. Churg A, Warnock ML. Asbestos fiber in the general population. Am Rev Respir Dis 1980;122:669-678.
93. Stasny JT, Husach C, Albright FR, Schumacher DV, Sweigart DW, Boyer K. Development of methods to isolate asbestos from spiked beverages and foods for SEM characterization. Scanning Electron Microsc 1979;1:587-595.
94. Sundius N, Bygden A Isolation of the mineral dust in lungs and sputum. J Ind Hyg Toxicol 1938;20:351-359.
95. Vallyathan V, Green FHY. The role of analytical techniques in the diagnosis of asbestos-associated disease. CRC Crit Rev Clin Lab Sci 1985;22:1-42.
96. Gylseth B, Baunan RH, Bruun R. Analysis of inorganic fibre concentrations in biological samples by scanning electron microscopy. Scand J Work Environ Health 1981;7:101-108.
97. Gylseth B, Baunan RH. Topographic and size distribution of asbestos bodies in exposed human lungs. Scand J Work Environ Health 1981;7:190-195.
98. O'Sullivan MF, Corn CJ, Dodson RF. Comparative efficiency of Nuclepore filters of various pore sizes as used in digestion studies of tissue. Environ Res 1987;43:97-103.
99. G10yne SR. The presence of the asbestos fibre in the lesions of asbestos workers. Tubercle 1929;10:404~07.
100. Sebastien P, Masse R, Bignon J. Recovery of ingested asbestos fibers from the gastrointestinal lymph in rats. Environ Res 1980;22:201-216.
101. Williams MG, Dodson RF, Corn C, Hurst GAA procedure for the isolation of amosite asbestos and ferruginous bodies from lung tissue and sputum. J Toxicol Environ Health 1982;10:627-638.
102. Gross P, Detreville RT. The lung as an embattled domain against inanimate pollutants. Am Rev Respir Dis 1972;106: 684-691.
103. Evans JC, Evans RJ, Holmes A, et al. Studies on the deposition of inhaled fibrous material in the respiratory tract of the rat and its subsequent clearance using radioactive tracer techniques. Environ Res 1973;6:180-201.
104. Pinkerton KE, Pratt PC, Brody AR, Crapo JD. Fiber localization and its relationship to lung reaction in rats after chronic inhalation of chrysotile asbestos. Am J Pathol 1984;117:484-498.
105. Coin PG, Roggli VL, Brody AR. Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ Res 1992;58: 97-116.
106. Lauweryns JM, Baert JH. Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir Dis 1977;115: 625-683.
107. Spencer H. The anatomy of the lung. In: Pathology of the lung, 4th ed. Oxford: Pergamon, 1985:417.
108. McMillan CH, Jones AD, Vincent JH, Johnston AM, Douglas AN, Cowie H. Accumulation of mixed mineral dusts in the lungs of rats during chronic inhalation exposure. Environ Res 1989;48:218-237.
109. Fishman AP. Pulmonary diseases and disorders. New York: McGraw-Hill, 1980:638.
110. Sebastien P, Jason X, Gaudichet A, Hirsch A, Bignon 1. Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura. In: Wagner JC, ed. Biological effects of mineral fibers. Lyon: IARC, 1980:237246.
111. Viallat JR, Raybuad F, Pass are I M, Boutin C. Pleural migration of chrysotile fibers after intratracheal injection in rats. Arch Environ Health 1986;41:282-286.
112. Dodson RF, O'Sullivan M, Huang J, Holiday DB, Hammar SP. Asbestos in extra pulmonary sites, omentum and mesentery. Chest 2000;117:486-493.
113. Dodson RF, O'Sullivan, Brooks DR, Bruce JR. Asbestos content of omentum and mesentery in nonoccupationally exposed individuals. Toxicol Ind Health 2001;17:138-143.
114. Hallenbeck WH, Patel-Mandlik K1. Presence of fibers in the urine of a baboon gavaged with chrysotile asbestos. Environ Res 1979;20:335-340.
115. Cook PM, Olson GF. Ingested mineral fibers: elimination in human urine. Science 1979;204:195-198.
116. Haque AK, Mancuso MG, Williams MG, Dodson RF. Asbestos in organs and placenta of five stillborn infants suggests transplacental transfer. Environ Res 1992;58: 163-175.
117. Dement JM. Overview: workshop of fiber toxicology research needs. Environ Health Perspect 1990;88:261-268.
118. U.S. Environmental Protection Agency. Asbestoscontaining materials in schools. Fed Reg 1991;40 CFR 763, Subpt. E, App. A, p.494.
119. Morgan A, Holmes A. The distribution and characteristics of asbestos fibers in the lungs of Finnish anthophyllite mine-workers. Environ Res 1984;33:62-75.
120. Case BW, Sebastien P, McDonald Jc. Lung fiber analysis in accident victims: a biological assessment of general environmental exposures. Arch Environ Health 1988;43: 178-179.
121. Dodson RF, O'Sullivan MF, Corn C1. Technique dependent variations in asbestos burden as illustrated in a case of nonoccupational exposed mesothelioma. Am J Ind Med 1993;24:235-240.
122. Roggli VL, Pratt PC, Brody AR. Asbestos content of lung tissue in asbestos-associated diseases. A study of 110 cases. Br J Ind Med 1986;43:18-28.
123. Churg A. Fiber counting and analysis in the diagnosis of asbestos-related disease. Hum PathoI1982;13:381-392.
124. Churg A, Wiggs B, Depaoli L, Kampe B, Stevens B. Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis 1984;130:1042-1045.
125. McDonald AD, McDonald JC, Pooley FD. Mineral fibre content of lung in mesothelial tumours in North America. Ann Occup Hyg 1982;26:417-422.
126. Dodson RF, O'Sullivan M, Corn CJ, McLarty JW, Hammar SP. Analysis of asbestos fiber burden in lung tissue from mesothelioma patients. Ultrastruct Pathol 1997;21:321-336.
127. Dodson RF, O'Sullivan M, Brooks DR, Hammar SP. Quantitative analysis of asbestos burden in women with mesothelioma. Am J Ind Med 2003;43:188-195.
128. Dodson RF, Brooks DR, O'Sullivan M, Hammar SP. Quantitative analysis of asbestos burden in a series of individuals with lung cancer and a history of exposure to asbestos. Inhal ToxicoI2004;16:637-647.
129. Dodson RF, Graef R, Shepherd S, O'Sullivan M, Levin 1. Asbestos burden in cases of mesothelioma from individuals from various regions of the United States. Ultrastruct PathoI2005;29:415-433.
130. Castranova V, Driscoll K, Harkema J, et al. The relevance of rat lung response to particle overloading for human risk assessment: a workshop consensus report. Inhal Toxicol 2000;12:1-17.
131. Pritchard IN. Dust overloading causes impairment of pulmonary clearance: evidence from rats and humans. Exp Pathol 1989;37:39-42.
132. Suzuki Y, Yuen SR. Asbestos tissue burden study on human malignant mesothelioma. Ind Health 2001;39:150-160.
133. Suzuki Y, Yuen SR. Asbestos fibers contributing to the induction of human malignant mesothelioma. Ann NY Acad Sci 2002;982:160-176.
134. Coin PG, Osornio-Vargas AR, Roggli VL, Brody AR. Pulmonary fibrogenesis after three consecutive inhalation exposures to chrysotile asbestos. Am J Respir Crit Care Med 1996;154:1511-1519.
135. Breedin PH, Buss DH. Ferruginous (asbestos) bodies in the lungs of rural dwellers, urban dwellers and patients with pulmonary neoplasms. South Med J 1976;69:401-404.
136. Dodson RF, Greenberg SD, Williams MG, Corn CJ, O'Sullivan MF, Hurst GA. Asbestos content in lungs of occupationally and non occupationally exposed individuals. JAMA 1984;252:68-71.
137. Becklake MR. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am Rev Respir Dis 1976;114:187-227.
138. Hillerdal G. The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities and impossibilities. Eur J Respir Dis 1980;61:129-138.
139. Churg A, Green FHY. Pathology of occupational lung disease. New York: Igaku-Shoin, 1988:213277.
140. Churg A. Nonasbestos pulmonary mineral fibers in the general population. Environ Res 1983;31:189-200.
141. Fulmer JD. Bronchoalveolar lavage. Am Rev Respir Dis 1982;126:961-962.
142. Crystal RG, Reynolds HY, Kalica AR. Bronchoalveolar lavage. The report of an international conference. Chest 1986;90:122-131.
143. Springmeyer Sc. The clinical use of bronchoalveolar lavage. Chest 1987;92:771-772.
144. Craighead JE, Mossman BT. The pathogenesis of asbestosassociated diseases. N Engl J Med 1982;306:1446-1455.
145. De Vuyst P, Dumortier P, Leophonte P, Vande Weyer R, Yernault Jc. Mineralogical analysis of bronchoalveolar lavage in talc pneumoconiosis. Eur J Respir Dis 1987;70: 150-156.
146. De Vuyst P, Dumortier P, Moulin E, et al. Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration. Eur Respir 1 1988;1:362-367.
147. De Vuyst P, Dumortier P, Moulin E, Yourassowsky N, Yernault Ie. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 1987;136: 1219-1224.
148. De Vuyst P, ledwab 1, Dumortier P, Vandermoten G, Vande Weyer R, Yernault Ie. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis 1982;126:972-976.
149. De Vuyst P, Mairesse M, Gaudichet A, Dumortier P,ledwab 1, Yernault Ie. Mineralogical analysis of bronchoalveolar lavage fluid as an aid to diagnosis of "imported" pleural asbestosis. Thorax 1983;38:628-629.
150. Dodson RF, Garcia IGN, O'Sullivan M, et al. The usefulness of bronchoalveolar lavage in identifying past occupational exposure to asbestos: a light and electron microscopy study. Am lInd Med 1991;19:619-628.
151. Dodson RF, O'Sullivan M, Brooks D, Levin LL. The sensitivity of lavage analysis by light and analytical electron microscopy in correlating the types of asbestos from a known exposure setting.Inhal ToxicoI 2003;15:461-471
152. Stewart Ml, Haddow Ae. Demonstration of the peculiar bodies of pulmonary asbestos in material obtained by lung puncture and in the sputum. J Pathol Bacteriol 1929;32: 1782.
153. McLarty lW, Greenberg SD, Hurst GA, et al. The clinical significance of ferruginous bodies in sputa. J Occup Med 1980;22:92-96.
154. Roggli VL, Greenberg SD, McLarty lW, et al. Comparison of sputa and lung asbestos body counts in former asbestos workers. Am Rev Respir Dis 1980;122:941.
155. Modin BE, Greenberg SD, Buffier PA, Lockhart lA, Seitzman LH, Awe RJ. Asbestos bodies in a general hospital/clinic population. Acta Cytol 1982;26:667-670.
156. Dodson RF, Williams MG, Corn Cl, Idell S, McLarty lW. Usefulness of combined light and electron microscopy evaluation of sputum samples for asbestos to determine past occupational exposure. Mod Pathol 1989;2:320-322.
157. Farley ML, Greenberg SD, Shuford EH, Hurst GA, Spivey CG, Christianson e. Ferruginous bodies in sputa of former asbestos workers. Acta Cytol 1977;21:693.
158. Churg A, Wood P. Observations on the distribution of asbestos fibers in human lungs. Environ Res 1983;31: 374-380.
159. Churg A, Wiggs B. The distribution of amosite asbestos fibers in the lungs of workers with mesothelioma or carcinoma. Exp Lung Res 1989;15:771-783.
160. Dodson RF, Hurst GA, Williams MG, Corn Cl, Greenberg SD. Comparison of light and electron microscopy for defining occupational asbestos exposure in transbronchial lung biopsies. Chest 1988;94:366-370.
161. Pritchard IN. Dust overloading causes impairment of pulmonary clearance: evidence from rats and humans. Exp Pathol 1989;37:39-42.
162. Cohen D, Arai SF, Brain ID. Smoking impairs long-term dust clearance from the lung. Science 1979;204:514-517.
163. McFadden D, Wright LL. Smoking inhibits asbestos clearance Am Rev Respir Dis 1986;133:372-374
164. McFadden D, Wright 1, Wiggs B, Churg A. Cigarette smoke increases the penetration of asbestos fibers into airway walls. Am 1 PathoI1986;123:95-99.
165. Stanton MF, Wrench e. Mechanisms of mesothelioma induction with asbestos and fibrous glass. 1 Natl Cancer Inst 1972;48:797-821.
166. Stanton MF, Layard M, Tegeris A, Miller E, May M, Kent E. Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. 1 Nat! Cancer Inst 1977;58:587-603.
167. Stanton MF, Layard M, Tegeris E, et al. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. 1 Nat! Cancer Inst 1981;67:965.
168. Selikoff IJ. Historical developments and perspectives in inorganic fiber toxicity in man. Environ Health Perspect 1990;88:269-276.
169. Wagner Ie. Asbestos cancers. 1 Nat! Cancer Inst 1979;52: 41-46.
170. Wagner lC, Pooley FD, Berry G, et al. A pathological and mineralogical study of asbestos-related deaths in the United Kingdom in 1977. Ann Occup Hyg 1982;26:423-431.
171. Dodson RF, Atkinson MAL, Levin LL. Asbestos fiber length as related to potential pathogenicity: a critical review Am lInd Med 2003;44:291-297
172. Pott F. Problems in defining carcinogenic fibres. Ann Occup Hyg 1987;31:799-802.
173. Pott F, Roller M, Ziem U, et al. Carcinogenicity studies on natural and manmade fibres with the intraperitoneal test in rats. In: Symposium on mineral fibres in the nonoccupational environment, Lyon, IARC Scientific Publ: 1989:173-179.
174. Pott F, Ziem U, Reiffer Fl, Huth F, Ernst H, Mohr U. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp PathoI1987;32:129-152.
175. Churg A. Chrysotile, tremolite, and malignant mesothelioma in man. Chest 1988;93:621-628.
176. Wagner Ie. Mesothelioma and mineral fibers. Cancer (Philadelphia) 1986;57:1905-1911.
177. Merchant lA. Human epidemiology: a review of type and characteristics in the development of malignant and nonmalignant disease. Environ Health Perspect 1990;88: 287-293.
178. Begin R, Gauthier 11, Desmeules M, Ostiguy G. Workrelated mesothelioma in Quebec, 1967-1990. Am lInd Med 1992;22:531-542.
179. Sebastien P, McDonald lC, McDonald AD, Case B, Harley R. Respiratory cancer in chrysotile textile and mining industries: exposure inferences from lung analysis. Br lInd Med 1989;46:180-187.
180. Dement 1M. Carcinogenicity of chrysotile asbestos: a case control study of textile workers. Cell Bioi Toxicol 1991;7: 59-65.
181. Davis IMG, 10nes AD. Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br 1 Exp PathoI1988;69:717-737.
182. Lippmann M. Asbestos exposure indices. Environ Res 1988;46:86-106.
183. Churg A, Wright LL.Rapid short-term clearance of chrysotile compared with amosite asbestos in the guinea pig Am Rev Respir Dis 1989;139:885-890
184. Churg A, Wright J, Wiggs B, Depaoli L. Mineralogic parameters related to amosite asbestos-induced fibrosis in humans. Am Rev Respir Dis 1990;142:1331-1336.
185. U.S. Environmental Protection Agency. Asbestos-containing materials in schools: final rule and notice. 40 CFR Part 763, Fed Reg 1987;52:41826-41905.
186. Warheit DB, Overby LH, George G, Brody AR Pulmonary macrophages are attracted to inhaled particles through complement activation. Exp Lung Res 1988;14: 51-66.
187. Till GO, Ward PA. Systemic complement activation and acute lung injury. Fed Proc 1986;45:13-18.
188. Bowden DH. Macrophages, dust, and pulmonary diseases. Exp Lung Res 1987;12:89-107.
189. du Bois RM. Advances in our understanding of the pathogenesis of fibrotic lung disease. Respir Med 1990;84: 185-187.
190. Shaw RJ, Benedict SH, Clark RAF, King TE. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Am Rev Respir Dis 1991;143:167-173.
191. Case BW, Ip MPC, Padilla M, Kleinerman L. Asbestos effects on superoxide production. Environ Res 1986;39:299-306.
192. Hansen K, Mossman BT. Generation of superoxide from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 1987;47:1681-1686.
193. Hansen K, Mossman BT. Generation of superoxide from alveolar macrophages exposed to asbestiform and from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 1987;47:1681-1686.
194. Ward PA, Duque RE, Sulavik MC, Johnson K1. In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Am J PathoI1983;110: 297-309.
195. Rahman Q, Das B, Viswanathan PN. Biochemical mechanisms in asbestos toxicity. Environ Health Perspect 1983;51:299-303.
196. Jaurand MC, Gaudichet A, Atassi K, Sebastien P, Bignon 1. Relationship between the number of asbestos fibres and the cellular and enzymatic content of bronchoalveolar fluid in asbestos exposed subjects. Bull Eur Physiopathol Respir 1980;16:595-606.
197. Brain JD. Macrophage damage in relation to the pathogenesis of lung diseases. Environ Health Perspect 1980;35: 21-28.
198. Hahon N, Vallyathan V, Booth JA, Sepulveda M1. In vitro biologic responses to native and surface-modified asbestos. Environ Res 1986;39:345-355.
199. Hayes AA, Rose AH, Musk AW, Robinson WS. Neutrophil chemotactic factor release and neutrophil alveoli tis in asbestos-exposed individuals. Chest 1988;94:521-525.
200. Dubois CM, Bissonnette E, Rola-Pleszczynski M.Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Respir Dis 1989;139:1257-1264.
201. Donaldson K, Li XY, Dogra S, Miller BG, Brown GM. Asbestos-stimulated tumour necrosis factor release from alveolar macro phages depends on fibre length and opsonization. J Pathol 1992;168:243-248.
202. Zone 11, Rom WN. Circulating immune complexes in asbestos workers. Environ Res 1985;37:383-389.
203. Huuskonen MS, Rasanen JA, Harkonen H, Asp S. Asbestos exposure as a cause of immunological stimulation. Scand J Respir Dis 1978;59:326-332.
204. Valerio F, Balducci D, Lazzarotto A. Adsorption of proteins by chrysotile and crocidolite: role of molecular weight and charge density. Environ Res 1987;44:312-320.
205. Hamilton JA. Asbestos fibers, plasma and inflammation. Environ Health Perspect 1983;51:281-285.
206. Bonneau L, Malard C, Pezerat H. Studies on surface properties of asbestos II. Role of dimensional characteristics and surface properties of mineral fibers in the induction of pleural tumors. Environ Res 1986;41:268-275.
207. Jolicoeur C, Poisson D. Surface physico-chemical studies of chrysotile asbestos and related minerals. Drug Chem ToxicoI1987;10:1-47.
208. Bonneau L, Suquet H, Malard C, Pezerat H. Studies on surface properties of asbestos I. Active sites on surface of chrysotile and amphiboles. Environ Res 1986;41:251-267.
209. Eberhardt MK, Roman-Franco AA, Quiles MR Asbestosinduced-decomposition of hydrogen peroxide. Environ Res 1985;37:287-292.
210. Kennedy TP, Ky H, Rao NV, et al. Asbestos and kaolin cause red cell hemolysis by acting as fenton reagents. Am Rev Respir Dis 1987;135:AI66.
211. Jaurand Me. Mechanisms of fibre genotoxicity. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991:287307.
212. MacDonald JL, Kane AB. Identification of asbestos fibers within single cells. Lab Invest 1986;55:177-185.
213. Brody AR, Hill LH, Stirewalt WS, Adler KB. Actincontaining microfilaments of pulmonary epithelial cells provide a mechanism for translocating asbestos to the interstitium. Chest 1983;83:11-12.
214. Somers ANA, Mason EA, Gerwin BI, Harris CC, Lechner JF. Effects of amosite asbestos fibers on the filaments present in the cytoskeleton of primary human mesothelial cells. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 481-490.
215. Aust AE, Lund LG. Iron mobilization from crocidolite results in enhanced iron-catalyzed oxygen consumption and hydroxyl radical generation in the presence of cysteine. In: Brown RC, Hoskins JA, Johnson NF, eds. Mechanisms in fibre carcinogenesis. New York: Plenum, 1991: 397-405.
216. Lund LG, Aust AE. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in OX174 RFI DNA. Carcinogenesis 1992;13:637-642.
217. Leanderson P, Tagesson e. Hydrogen peroxide release and hydroxyl radical formation in mixtures containing mineral fibres and human neutrophils. Br J Ind Med 1992;49:745-749.
218. Lund LG, Williams MG, Dodson RF, Aust AE. Iron associated with asbestos bodies is responsible for the formation of single-strand breaks in OX174 RFI DNA. Occup Environ Med 1994;51:200-204.
219. Becklake MR Occupational lung disease: past record and future trend using the asbestos case as a model. Clin Invest Med 1983;6:305-317.
220. Dressen WC, Dallavalle 1M, Edward TI, Miller 1M, Sayers RR. The study of asbestos in the asbestos textile industry. Public Health Bulletin No.
221. Washington, DC: U.S. Treasury Department, 1938:1-126.
222. Merewether ERA, Price CWo Report on the effects of asbestos dust on the lungs and dust suppression in the asbestos industry. London: HM Stationery Office, 1930: 1-34.
223. Hillerdal G, Ozesmi M. Benign pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987;71:113-121.
224. Robinson BWS, Musk AW. Benign asbestos pleural effusion: diagnosis and course. Thorax 1981;36:896-900.
225. Lillis R, Lerman Y, Selikoff IJ. Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities. Br J Ind Med 1988;45: 443-449.
226. Miller A, Miller JA. Diffuse pleural thickening superimposed on circumscribed pleural thickening and related to asbestos exposure. Am J Ind Med 1993;23:859-871.
227. Miller A. Chronic pleuritic pain in four patients with asbestos induced pleural fibrosis. Br J Ind Med 1990;47: 147-153.
228. Epler GR, McCloud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982;247:617-622.
229. Gaensler EA, Kaplan AI. Asbestos pleural effusion. Ann Intern Med 1971;74:178-191.
230. Collins TFB. Pleural reaction associated with asbestos exposure. Br J RadioI1968;41:655-661.
231. Mattson S, Ringqvist T. Pleural plaques and exposure to asbestos. Scand J Respir Dis 1970;75(SuppI.):I-41.
232. Mattson S. Monosymptomatic exudative pleurisy in persons exposed to asbestos dust. Scand J Respir Dis 1975;56:263-272.
233. Eisenstadt HB. Asbestos pleurisy. Dis Chest 1964;46:78-81.
234. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987;71: 113-12l.
235. Fondimare A, Duwoos H, Desbordes J, et aI. Plaques fibroyalines calcifiees du foie dans l"asbestose. Nouv Presse Med 1973;3:893.
236. Andrion A, Pira E, Mollo F. Peritoneal plaques and asbestos exposure. Arch Pathol Lab Med 1983;107:609-610.
237. Wain SL, Roggli VL, Foster WL II. Parietal pleural plaques, asbestos bodies, and neoplasia: a clinical, pathologic and roentgenographic correlation of 25 consecutive cases. Chest 1985;86:707-713.
238. Schwartz DA. New developments in asbestos-induced pleural disease. Chest 1991;99:191-198.
239. Rogan WJ, Gladen BC, Regan NB, Anderson HA. US prevalence of occupational pleural thickening: a look at X-rays from the First National Health and Nutrition Examination Survey. Am J Epidemiol 1987;126:893-900.
240. Miller JA, Zurlo Jv. Asbestos plaques in a typical veterans hospital population. Am J Ind Med 1996;30:726-729.
241. Hourihane DO, Lessof L, Richardson Pc. Hyaline and calcified pleural plaques as an index of exposure to asbestos: a study of radiological and pathological features of 100 cases with a consideration of epidemiology. Br Med J 1966;1:1069-1074.
242. Warnock ML, Prescott BT, Kuwahara TJ. Numbers and types of asbestos fibers in subjects with pleural plaques. Am J PathoI1982;109:37-46.
243. Rohl AN. Asbestos in talc. Environ Health Perspect 1974;9:129-132.
244. Hillerdal G. Pleural plaques in a health survey material: frequency, development and exposure to asbestos. Scand J Respir Dis 1978;59:257-263.
245. Sebastien P, Fondimare A, Bignon J, Monchaux G, Desbordes J, Bonnaud G. Topographic distribution of asbestos fibres in human lung in relation to occupational and nonoccupational exposure. In: Walter WH, McGovern B, eds. Inhaled particles. New York: Pergamon Press, 1977;4: 435-444.
246. Whitwell F, Scott J, Grimshaw M. Relationship between occupations and asbestos fibre content of the lungs in patients with pleural mesothelioma, lung cancer, and other diseases. Thorax 1977;32:377-386.
247. Churg A. Asbestos fibers and pleural plaques in a general autopsy population. Am I Pathol 1982;109:88-96.
248. Churg A, dePaoli L. Environmental pleural plaques in residents of a Quebec chrysotile mining town. Chest 1988;94:58-60.
249. Kishimoto T, Ono T, Okada K, Ito H. Relationship between numbers of asbestos bodies in autopsy lung and pleural plaques on chest X-ray film. Chest 1989;95:549-552.
250. Lee KP Lung response to particles with emphasis on asbestos and other fibrous dusts. CRC Crit Rev Toxicol 1985;14:33-86.
251. Meurman L. Asbestos bodies and pleural plaques in a Finnish series of autopsy cases. Acta Pathol Microbiol Scand 1966;181(suppl):7-107.
252. Roberts GH. The pathology of parietal pleural plaques. J Clin Pathol 1961;24:348-353.
253. LeBouffant L, Martin JC, Durif S, Daniel H. Structure and composition of pleural plaques. In: Bogovski P, Gilson JC, Timbrell V, Wagner lC, eds. Biological effects of asbestos. Lyon, France: International Agency for Research on Cancer, 1973:249257.
254. Kiviluoto R. Pleural calcification as a roentgenologic sign of nonoccupational endemic anthophyllite asbestosis. Acta Radiol 1960;194(suppl):1-67.
255. Wang NS. The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura. Am Rev Respir Dis 1975; 111:12-20.
256. Moalli PA, MacDonald LL., Acute injury and regeneration of the mesothelium in response to asbestos fibers, Am i Pathoi, 1987, 128, 426-445.
257. Taskinen E, Ahlmon K, Wiikeri M. A current hypothesis of the lymphatic transport of inspired dust to the parietal pleura. Chest 1973;64:193-196.
258. Wagner JC, Berry G, Skidmore JW, Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer 1974;29:252-269.
259. Hammar SP Controversies and uncertainties concerning the pathologic features and pathologic diagnosis of asbestosis. Semin Diagn Pathol 1992;9:102-109.
260. Stephens M, Gibbs AR, Pooley FD, Wagner Jc. Asbestosinduced diffuse pleural fibrosis: pathology and mineralogy. Thorax 1987;42:583-588.
261. Gibbs AR, Stephens M, Griffiths DM, Blight BJN, Pooley FD. Fiber distribution in the lungs and pleura of subjects with asbestos-related diffuse pleural fibrosis. Br J Ind Med 1991;48:762-770.
262. Kilburn KH, Warshaw R Pulmonary functional impairment associated with pleural asbestos disease: circumscribed and diffuse thickening. Chest 1990;98:965-972.
263. Loeschke H. Storungen des Lufgehalts der Lunge. In: Hanke-Lubarsch Hanbuch der Spezielleu pathologischen Anatomie and Histologie. 3. Bd, 1. Teil. Berlin: Springer, 1928:599.
264. Hanke R Rundatelektasen (Kugel and Walzenatelektasen): ein bietrag zur differential diagnosis intrapulmonaler rundherde. Fortschr Geb Rontgenstr Nuklearmed 1971;114:164-183.
265. Blesovsky A. The folded lung. Br J Dis Chest 1966;60: 19-22.
266. Dernevik L, Gatzinsky P, Hultman E, et al. Shrinking pleuritis with atelectasis. Thorax 1982;37:252-258.
267. Payne CR, Jaques P, Kerr IH. Lung folding simulating peripheral pulmonary neoplasm (Blesovsky's syndrome). Thorax 1980;35:936-940.
268. Sinner WN. Pleuroma. A cancer-mimicking atelectatic pseudotumor of the lung. Rofo 1980;133:578-585.
269. Kretzschmar R Uber atelaktatische pseudotumoren der Lunge. Rofo 1975;122:19-29.
270. Schummelfeder N. Urnfaltungen and verwachsungen an freien Lungenradem. Beitr Pathol Anal Allg Pathol 1956;116:422-435.
271. Giese W. Pathologische anatomie der pleuaerkrankeungen. Prax PneumoI1972;26:574-587.
272. Mark EJ. Case 24-1983. N Engl J Med 1983;308:1466-1472.
273. Menzies R, Fraser R Round atelectasis: pathologic and pathogenetic features. Am J Surg Pathol 1987;11:674-681.
274. Chung-Park M, Tomashefski JF, Jr., Cohen AM, EI-Gazzar M, Cotes EE. Shrinking pleuritis with lobar atelectasis: a morphologic variant of "round atelectasis." Hum Pathol 1989;20:382-387.
275. Boutin C, Dumorlier P, Rey F, et al. Black spots concentrate oncogenic asbestos fibers in the parietal pleura: thoracoscopic and mineralogic study. Am J Respir Crit Care Med 1996;153:444-449.
276. Mitchev K, Dumortier P, DeVuyst P. "Black spots" and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol 2002;26:1198-1206.
277. Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest 2004;125:1103-1117.
278. Guidotti TL, Miller A, Christi ani D, et al. Ad Hoc Statement Committee of the Scientific Assembly on Environmental and Occupational Health of the American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004;170:691-715.
279. Ferrer J, Balcells E, Orriols R, et al. Benign asbestos pleural effusion. Report of a first series in Spain. Med Clin (Barc) 1996;107:535-538.
280. Cohen M, Sahn SA. Resolution of pleural effusions. Chest 2001;119:1547-1562.
281. Lillis R, Lerman Y, Selikoff IJ. Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities. Br J Ind Med 1998;23: 859-871.
282. Bendjelid K, Pugin J. Is Dressler syndrome dead? Chest 2004;126:1680-1682.
283. Ren H, Lee DR, Hruban RH, et al. Pleural plaques do not predict asbestosis: high-resolution computed tomography and pathology study. Mod PathoI1991;4:201-209.
284. Fitzgerald EF, Stark AD, Vianna N et al. Exposure to asbestiform minerals and radiographic chest abnormalities in a talc mining region of upstate New York. Arch Environ Health 1991;46:151-154.
285. Gilmartin D. The serratus anterior muscle on chest radiograph. Radiology 1979;131:629-635.
286. Rockoff SD, Chu J, Rubin LJ. Special reports: asbestosinduced pleural plaques; a disease process associated with ventilatory impairment and respiratory symptoms. Clin Pulmon Med 2002;9:113-124.
287. Schwartz DA, Fuortes LJ, Galvin JR, et al. Asbestosinduced pleural fibrosis and impaired lung function. Am Rev Respir Dis 1990;141:321-326.
288. Jarvolm B, Sanden A. Pleural plaques and respiratory function. Am J Ind Med 1986;10:419-426.
289. Hjorstberg U, Orbaek P, Aborelios M et al. Railroad workers with pleural plaques. 1. Spirometric and nitrogen washout investigation on smoking and nonsmoking asbestos-exposed workers. Am J Ind Med 1988;14: 635-641.
290. Oliver LC, Eisen EA, Green R, Sprince NL. Asbestosrelated pleural plaques and lung function. Am J Ind Med 1988;14:649-656.
291. Lillis R, Miller A. Godbold J, et al. Pulmonary function and pleural fibrosis: quantitative relationships with an integrative index of pleural abnormalities. Am J Ind Med 1991;20:145-161.
292. VanCleemput J, De Raeve H, Verschakelen G, et al. Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function. Am J Respir Crit Care Med 2001;163:705-710.
293. Selikoff IJ, Lee DHK. Asbestos and disease. New York: Academic Press, 1978.
294. Craighead JE. Eyes for the epidemiologist: the pathologist's role in shaping our understanding of asbestos-associated diseases. Am J Clin Pathol 1988;89:281-287.
295. Cooke WE. Pulmonary asbestosis. Br Med J 1927;2:1024-1025.
296. Dresen WC, Dallavalle JM, Edward TI, Miller JM, Sayers RR A study of asbestos in the asbestos textile industry. Public Health Bulletin No. 24. Washington, DC: U.S. Treasury Department, 1938:1126.
297. Roggli VL, Shelburne JD. New concepts in the diagnosis of mineral pneumoconiosis. Semin Respir Med 1982;4: 128-138.
298. Roggli VL. Pathology of human asbestosis: a critical review. Adv PathoI1989;2:31-60.
299. Roggli VL. Asbestosis. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of asbestos-associated diseases. Boston: Little, Brown, 1992:77108.
300. Winterbauer RH, Hammar Sp, Hallman Ko. Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisone/ azathioprine. Am J Med 1977;65:661-672.
301. Churg A, Sakoda N, Warnock ML. A simple method of preparing ferruginous bodies for electron microscopic examination. Am J Clin PathoI1976;68:513-517.
302. Churg A. Non-neoplastic diseases caused by asbestos. In: Churg A, Green FHY, eds. Pathology of occupational lung diseases. New York: Igaku-Shoin, 1988:253277.
303. Churg A, Wright JL. Small airway lesions in patients exposed to non asbestos mineral dusts. Hum PathoI1983;14: 688-693.
304. Wright JL, Cagle P, Churg A, Colby TV, Myers 1. Diseases of the small airways. Am Rev Respir Dis 1992;146:240-262.
305. Helsinki Consensus Report. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997;23:311-316.
306. Wagner JC, Newhouse ML, Corrin B, et al. Correlation between fibre content of the lung and disease in East London asbestos factory workers. Br J Ind Med 1988;45: 305-308.
307. Vorward AJ, Durkan TM, Pratt Pc. Experimental studies of asbestosis. Arch Ind Hyg Occup Med 1951;3: 1-43.
308. Wright GW, Kuschner M. The influence of varying length of glass and asbestos fibers on tissue response in guinea pigs. In: Walton WH, ed. Inhaled particles IV. Oxford: Pergamon Press, 1977:455474.
309. Davis JMG, Beckett ST, Bolton RE, Collings P, Middleton AP Mass and the number of fibers in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer 1978;37: 673-688.
310. Crapo JD, Barry BE, Brody AR, O'Neil JJ. Morphological, morphometric and X-ray microanalytical studies on lung tissue of rats exposed to chrysotile asbestos in inhalation chambers. In: Wagner JC, ed. Biological effects of mineral fibers. Lyon, France: IARC Scientific Publications, 1980: 273-283.
311. Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats through inhalation and intraperitoneal injection. Br J Exp Pathol 1986;67:415-430.
312. Adamson IYR, Bowden DH. Response of mouse lungs to crocidolite asbestos. I. Mineral fibrotic reaction to short fibers. J PathoI1987;152:99-107.
313. Adamson IYR, Bowden DH. Response of mouse lungs to crocidolite asbestos. II. Pulmonary fibrosis after long fibres. J PathoI1987;152:109-117.
314. McDonald AD, Fry JS, Woolley AJ, McDonald Jc. Dust exposure and mortality in an American chrysotile textile plant. Br J Ind Med 1983;40:361-367.
315. Dodson RF, Williams MG, Huang J, Bruce JR. Tissue burden of asbestos in nonoccupationally exposed individuals from East Texas. Am J Ind Med 1999;35: 281-286.
316. Gylseth B, Churg A, Davis JMG, et al. Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung: an international interlaboratory trial. Scand J Work Environ Health 1985;11:107-110.
317. Bellis D, Andrion A, Desedime L, et al. Minimal pathologic changes of the lung and asbestos exposure. Hum Pathol 1989;20:102-106.
318. Rom WN, Travis WD, Brody AR. Cellular and molecular basis of asbestos-related diseases. Am Rev Respir Dis 1991;143:408-422.
319. Hartman DP Immunological consequences of asbestos exposure. Immunol Rev 1985;4:65-68.
320. Kagan E. The alveolar macrophage: immune derangement and asbestos-related malignancy. Semin Oncol 1980;8: 258-267.
321. Spurzem JR, Saltini C, Rom W, et al. Mechanism of macrophage accumulation in the lungs of asbestos subjects. Am Rev Respir Dis 1987;136:276-280.
322. Dubois CM, Bissonnette E, Rola-Pleszycynski M. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am Rev Respir Dis 1989;139:1257-1264.
323. Lemaire I, Beaudoin H, Masse S, et al. Alveolar macrophage stimulation of lung fibroblast growth in asbestosinduced pulmonary fibrosis. Am J Pathol 1986;122: 205-211.
324. Timbrell V, Ashcroft T, Goldstein B, et al. Relationships between retained amphibole fibers and fibrosis in human lung tissue specimens. Ann Occup Hyg 1988;32:323-340.
325. Begin R, Masse S, Bureau MA. Morphologic features and function of the airways in early asbestosis in the sheep model. Am Rev Respir Dis 1982;126:870-876.
326. Harless KW, Watanabe S, Renzetti AD. The acute effects of chrysotile asbestos exposure on lung function. Environ Res 1978;16:360-372.
327. Jodoin G, Gibbs GW, Macklem PT, McDonald JC, Becklake MR. Early effects of asbestos exposure on lung function. Am Rev Respir Dis 1971;104:525-535.
328. Jacob G, Bohling H. Das verhalten des bronchialbaumes bei der asbestaublunge.Arch Gewerbepathol Gewerbehyg 1960;18:247-257.
329. Pinkerton KE, Plopper GC, Mercer RR, et al. Airway branching patterns influence asbestos fiber location and the extent of tissue injury in the pulmonary parenchyma. Lab Invest 1986;55:688-695.
330. Delfino R, Ernst P, Bourbeau 1. Relationship of lung geometry to the development of pleural abnormalities in insulation workers exposed to asbestos. Am J Ind Med 1989;15:417-425.
331. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998;157:1666-1680.
332. Attanoos RL, Gibbs AR, Corrin B. The dilemma of "asbestosis" or lung fibrosis: a case referent necropsy study of 188 asbestos exposed naval dockyard workers and 175 UK non-exposed "control" subjects. Mod Pathol 2006;1:302A.
333. Churg A, Tron V, Wright JL. Effects of cigarette smoke exposure on retention of asbestos fibers in various morphologic compartments of the guinea pig lung. Am J Pat hoi 1987;129:385-393.
334. Barnhart S, Thornquist M, Omen GS, et al. The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects. Am Rev Respir Dis 1990;141:1102-1106.
335. Blanc PD, Gamsu G. The effect of cigarette smoking on the detection of small radiographic opacities in inorganic dust diseases. J Thorac Imag 1988;3:51-56.
336. Weiss W. Cigarette smoking and small irregular opacities. Br J Ind Med 1991;48:841-844.
337. Weiss W. Smoking and pulmonary fibrosis. J Occup Med 1988;30:33-39.
338. Murphy RL, Becklake MR, Brooks SM, et al. The diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 1986;134:363-368.
339. Huuskonen MS. The clinical features, mortality and survival of patients with asbestosis. Scand J Work Environ Health 1978;4:265-274.
340. Becklake MR. Asbestosis criteria. Arch Pathol Lab Med 1984;108:93.
341. Robinson BWS, Rose AH, James A, Whitaker D, Musk AW. Alveolitis of pulmonary asbestosis: bronchoalveolar lavage studies in crocidolite-and chrysotile-exposed individuals. Chest 1986;90:396-402.
342. Gaensler EA, Jederline PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991;144:689-696.
343. Roggli VL. Scanning electron microscopic analysis of mineral fiber content of lung tissues in the evaluation of diffuse pulmonary fibrosis. Scanning Microsc 1991;5: 71-83.
344. Monso E, Tura JM, Morell F, Ruiz J, Morera I Lung dust content in idiopathic pulmonary fibrosis: a study with scanning electron microscopy and energy-dispersive X-ray analysis. Br J Ind Med 1991;48:327-331.
345. Hillerdal G, Hemmingson A. Pulmonary pseudotumors and asbestos. Acta Radiol Diagn 1980;21(Facs. 5):615-620.
346. Lynch DA, Gamsu G, Ray CS, Aberle DR. Asbestosrelated focal lung masses: manifestations on conventional and high-resolution CT scans. Radiology 1988;169:603-607.
347. Case Records of the Massachusetts General Hospital. Case 73-1961. N Engl J Med 1961;265:745-751.
348. Saldana MI Localized asbestos pneumonia. Lab Invest 1981;44:57 A-58A(abstr).
349. Spencer H. The pneumoconioses and other occupational lung diseases. In: Pathology of the lung, 3rd ed. Oxford: Pergamon Press, 1977:427-429.
350. Hammar SP, Hallman Ko. Localized inflammatory pulmonary disease in persons occupationally exposed to asbestos. Chest 1993;103:1792-1799.
351. Keith I, Day R, Lemaire S, Lemaire I. Asbestos-induced fibrosis in rats: increase in lung mast cells and autocoid contents. Exp Lung Res 1987;13:311-327.
352. Corrin B, Price AB. Electron microscopic studies in desquamative interstitial pneumonia associated with asbestos. Thorax 1972;27:324-33l.
353. Freed JA, Miller A, Gordon RE, Fischbein A, Kleinerman J, Langer AM. Desquamative interstitial pneumonia associated with chrysotile asbestos fibers. Br J Ind Med 1991;48:332-337.
354. Hillerdal G, Heckscher T. Asbestos exposure and Aspergillus infection. Eur J Respir Dis 1982;63:420-424.
355. Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis. Thorax 1952;7:317-333.
356. Roggli VL, Johnson WW, Kaminsky DB. Asbestos bodies in fine needle aspirates of the lung. Acta Cytol 1984;28: 493-498.
357. Monseur J, Leguene B, Lebouffant L, Tichoux G. Asbestose du col vesical et de la prostate. J Urol 1986;92:17-21.
358. De Vuyst P, Dumortier P, Schandene L, Esenne M, Verhest A, Yernault I Sarcoid-like lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 1987;135:493-497.
359. Rom WN, Travis WD. Lymphocyte-macrophage alveoli tis in non-smoking individuals occupationally exposed to asbestos. Chest 1992;101:779-786.
360. Greenberg SD, Roggli VL. Carcinoma of the lung. In: Roggli VL, Greenberg SD, Pratt PC, eds. The pathology of asbestos-associated diseases. Boston: Little, Brown, 1992: 189-210.
361. Wood WB, Gloyne SR. Pulmonary asbestosis: a review of one hundred cases. Lancet 1934;2:1383-1385.
362. Gloyne SR. Two cases of squamous carcinoma of the lung occurring in asbestosis. Tubercle 1935;17:5-10.
363. Egbert DS, Geiger Al Pulmonary asbestosis and carcinoma: report of a case with necropsy findings. Am Rev Tuberc 1936;34:143-150.
364. Hruby AJ, Sweany He. Primary carcinoma of lung with special reference to incidence, early diagnosis and treatment. Arch Intern Med 1933;52:497-540.
365. Klotz 0, Simpson W. Silicosis and carcinoma of lung. Libman Annu 1932;2:685-691.
366. Obendorfer S. Das lungenkarzinom. Munchen Med Wochenschr 1933;80:688-696.
367. Lynch KM, Smith WA. Pulmonary asbestosis. III. Carcinoma of the lung in asbestosis. Am J Cancer 1936;14: 56-64.
368. Nordmann M. Der Berufskrebs der Asbestarbeiter. Z Krebsforsch 1938;47:288-302.
369. Nordmann M, Sorge A. Lungenkrebs durch Asbestaub im Tierversuch. Z Krebsforsch 1941;51:168-178.
370. Wedler HW. Uber den Lungenkrebs bei Asbestose. Dtsch Med Wochenschr 1943;69:575-576.
371. Merewether ERA. Annual report of the Chief Inspector of Factories for the year 1947. London: HM Stationery Office, 1949:7881.
372. Enterline PE. Asbestos and cancer: the international lag. Am Rev Respir Dis 1978;118:975-978.
373. Berry G. Changing opinions and attitudes regarding asbestos and cancer. Am J Ind Med 1992;22:447-448.
374. Bignon I How are we going to change our attitudes and opinions regarding asbestos and cancer in the next 20 years? Am J Ind Med 1992;22:443-446.
375. Egilman DS. Public health and epistemology. Am J Ind Med 1992;22:457-459.
376. Lerman YAsbestos and cancer 1943-1965. And what happened thereafter? Am J Ind Med 1992;22:455-456.
377. Levin SM. Prevention delayed is prevention denied. Am J Ind Med 1992;22:435-436.
378. Morgan RW. Attitudes about asbestos and lung cancer. Am J Ind Med 1992;22:437-441.
379. Schepers GWH. Changing attitudes and opinions: asbestos and cancer, 1934-1965. Am J Ind Med 1992;22:461-466.
380. Wikeley NI Asbestos and cancer: an early warning to the British TVe. Am J Ind Med 1992;22:449-454.
381. Keane 1. Changing attitudes and opmlOns regarding asbestos and cancer, 1934-1965. Am lInd Med 1992; 22:429-433.
382. Doll R. Mortality from lung cancer in asbestos workers. Br 1 Tnd Med 1955;12:81-86.
383. McDonald lC Asbestos and lung cancer: has the case been proven? Chest 1980;67(suppl):374-376.
384. Acheson ED, Gardner M1. The ill effects of asbestos on health. In: Health and Safety Commission. Asbestos. Final report of the Advisory Committee, vol. 2. London: HM Stationery Office, 1979:784.
385. Selikoff IJ, Churg 1, Hammond EC Asbestos exposure and neoplasia. lAMA 1964;188:22-26.
386. Browne K. Asbestos-related malignancy and the Cairns hypothesis. Br lInd Med 1991;48:73-76.
387. Boyland E. Tumour initiators, promoters and complete carcinogens. Br lInd Med 1985;42:716-718.
388. Trosic I, Horvat D, Stilinovic L, Pisl Z. Cytotoxic, hemolytic and mutagenic issue caused by chrysotile asbestos in vitro. Tn: Mossman BT, Begin RO, eds. Effect of mineral dusts on cells. New York: Springer-Verlag, 1988:423437.
389. Barrett lC, Lamb PW, Wiseman RW. Multiple mechanisms for the carcinogenic effect of asbestos and other mineral fibers. Environ Health Perspect 1989;81:81-89.
390. Selikoff IJ, Lee DHK. Asbestos and disease. New York: Academic Press, 1982.
391. Kannerstein M, Churg 1. Mesothelioma in man and experimental animals. Environ Health Perspect 1980;34:31-36.
392. Hesterberg TW, Barett lC Induction by asbestos fibers of anaphase abnormalities: mechanism for aneuploidy induction and possible carcinogenesis. Carcinogenesis 1985;6: 473-475.
393. Craighead JE, Akley Nl, Gould LB, Libbus BNL. Characteristics of tumors and tumor cells cultured from experimental and asbestos-induced mesotheliomas in rats. Am I Pathol 1987;129:448-462.
394. Lechner IF, Tokiwa T, La Veck MA, et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc Nat! Acad Sci USA 1985;82:3884-3888.
395. Fatima N, lain AK, Rahman Q. Frequency of sister chromatid exchange and chromosomal aberrations in asbestos cement workers. Br lInd Med 1991;148:103-105.
396. Rom WN, Livingston GK, Casey KR, et al. Sister chromatid exchange frequency in asbestos workers. 1 Nat! Cancer Inst 1983;70:45-48.
397. International Agency for Research on Cancer. Evaluation of the carcinogenic risk of chemicals to humans. IARC Monograph 1-29(4). Geneva: World Health Organization, 1982.
398. Walker C, Everett J, Barret J C Possible cellular and molecular mechanisms for asbestos carcinogenicity. Am lInd Med 1992;21:253-273.
399. Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax 1999;54:638-652.
400. Atkinson MAL. Molecular and cellular responses to asbestos exposure. In: Dodson RF, Hammar Sp, eds. Asbestos: risk assessment, epidemiology and health effects. Boca Raton, FL: CRC-Taylor Francis, 2006:91136.
401. Selikoff El, Hammond EC, Churg 1. Asbestos exposure, smoking, and neoplasia. lAMA 1968;204:104-110.
402. Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987;9:175-193.
403. Liddell FDK, Thomas DC, Gibbs lW, et al. Fibre exposure and mortality from pneumoconiosis, respiratory and abdominal malignancies in chrysotile production in Quebec, 1926-75. Singapore Ann Acad Med 1984;13 (suppI2):340-344.
404. Baker IE. Lung cancer incidence amongst previous employees of an asbestos mine in relationship to croci dolite exposure and tobacco smoking. PhD thesis, University of Western Australia, Perth, 1985.
405. Selikoff IJ, Seidman H, Hammond EC Mortality effects of cigarette smoking among amosite asbestos factory workers. J Nat Cancer Inst 1980;65:507-513.
406. Acheson ED, Gardner Ml, Winter PD, et al. Cancer in a factory using amosite asbestos. Int J Epidemiol 1984;13: 3-10.
407. Berry G, Newhouse ML, Antonis P. Combined effect of asbestos exposure and smoking on mortality from lung cancer in factory workers. Lancet 1972;2:476-479.
408. Berry G, Newhouse ML, Antonis P. Combined effect of asbestos and smoking on mortality from lung cancer and mesothelioma in factory workers. Br lInd Med 1985;42: 12-18.
409. Selikoff IJ, Hammond ED. Multiple risk factors in environmental cancer. In: Fraumeni 1, ed. Persons at high risk of cancer. New York: Academic Press, 1975:467-483.
410. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann NY Acad Sci 1979;330:473-490.
411. Blot WI, Harrington 1M, Toledo A, et al. Lung cancer after employment in shipyards during World War II. N Engl 1 Med 1978;299:620-624.
412. Blot WI, Morris LE, Stroube R, et al. Lung and laryngeal cancer in relation to shipyard employment in coastal Virginia. l Nat! Cancer Inst 1980;65:571-575.
413. Martischnig KM, Newell Dl, Barnsley WC, et al. Unsuspected exposure to asbestos and bronchogenic carcinoma. Br Med 11977;1:746-749.
414. Pastorino U, Berrino F, Gervasio A, et al. Proportion of lung cancers due to occupational exposure. Int 1 Cancer 1984;33:231-237.
415. Kjuus H, Skjaerven R, Langard S, et al. A case-referent study of lung cancer, occupational exposure and smoking. 2. Role of asbestos exposure. Scand 1 Work Environ Health 1986;12:203-209.
416. Berry G. Mortality of workers certified by pneumoconiosis medical panels as having asbestosis. Br lInd Med 1981;38:130-137.
417. Finkelstein M, Kusiak R, Suranyi G. Mortality among workers receiving compensation for asbestosis in Ontario. Can Med Assoc 1 1981;125:259-262.
418. Cookson WO, Most AW, Glancy 11, et al. Compensation, radiographic changes, and survival in applicants for asbestosis compensation. Br lInd Med 1985;42:461-468.
419. Coutts IJ, Gilson lC, Kerr IH, et al. Mortality in cases of asbestosis diagnosed by a pneumoconiosis medical panel. Thorax 1987;42:111-116.
420. Weill H. Asbestos. A summing up. In: Wagner lC, ed. Biological effects of mineral fibers, vol. 2. TARC Publication No. 30. Lyon: International Agency for Research on Cancer, 1980:867873.
421. Kipen HM, Lilis R, Suzuki V, Valciukas JA, Selikoff IJ. Pulmonary fibrosis in asbestos insulation workers with lung cancer: a radiological and histopathological evaluation. Br J Ind Med 1987;44:96-100.
422. Newhouse ML, Berry G, Wagner Je. Mortality of factory workers in East London, 1933-1980. Br J Ind Med 1985;42:4-11.
423. Sluis-Cremer GK, Bezuidenhout B N. Relation between asbestosis and bronchial cancer in amphibole miners. Br J Ind Med 1989;46:537-540.
424. Hughes HJM, Weill H. Asbestosis as a precursor of asbestos-related lung cancer: results of a prospective mortality study. Br J Ind Med 1991;48:229-233.
425. Browne K. Is asbestos or asbestosis the cause of the increased risk of lung cancer in asbestos workers? Br J Ind Med 1986;43:145-149.
426. Henderson DW, deKlerk NH, Hammar SP, et al. Asbestos and lung cancer: is it attributable to asbestosis or asbestos fiber burden? In: Corrin B, ed. Pathology of lung tumors. New York: Churchill-Livingstone, 1997:83118.
427. Henderson DW, Rodelsperger K, Woitowitz HJ, Leigh 1. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology 2004;36:517-550.
428. Cullen MR, Barnett MJ, Balmes JR, et al. Predictors of lung cancer among asbestos-exposed men in the betacarotene and retinol efficacy trial. Am J Epidemiol 2005;161:260-270.
429. Reid A, deKlerk N, Ambrosini GL, et al. The effect of asbestos on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med 2005;62:885-889.
430. Kiviluoto R, Meurman LO, Hakama M. Pleural plaques and neoplasia in Finland. Ann NY Acad Sci 1979;330: 31-33.
431. Edge JR. Incidence of bronchial carcinoma in shipyard workers with pleural plaques. Ann NY Acad Sci 1979;330: 289-294.
432. Hillerdal G. Pleural plaques and risks for cancer in the county of Uppsala. Eur J Respir Dis 1980;61(suppl): 111-117.
433. Mollo F, Andrion A, Colombo A, Segnan N, Pira E. Pleural plaques and risk of cancer in Turin, Northwestern Italy. Cancer (Philadelphia) 1984;54:1418-1422.
434. Harber P, Mohsenifar Z, Oren A, Lew M. Pleural plaques and asbestos-associated malignancy. J Occup Med 1987;29: 641-644.
435. Hillerdal G. Risk and type of lung cancer and mesothelioma in patients with pleural plaques. Lung Cancer 1991; 7(suppl):5.
436. Partanen T, Nurimen M, Zitting A, Koskinen H, Wiikeri M, Ahlman K. Localized pleural plaques and lung cancer. Am J Ind Med 1992;22:185-192.
437. Hillerdal G, Henderson DW. Asbestos, asbestosis, pleural plaques and lung cancer. Scand J Work Environ Health 1997;23:93-103.
438. Parkes WR. Occupational lung disorders, 2nd ed. London: Butterworths, 1982.
439. Medical Advisory Panel to the Asbestos International Association. Criteria for the diagnosis of asbestosis and considerations in the attribution of lung cancer and mesothelioma to asbestos exposure. Int Arch Occup Environ Health 1982;49:357-361.
440. Whitwell F, Newhouse MI, Bennett DR. A study of the histological types of lung cancer in workers suffering from asbestosis in the United Kingdom. Br J Ind Med 1974;31: 298-303.
441. Churg A. Lung cancer cell type and asbestos exposure. JAMA 1985;253:2984-2985.
442. Hourihane DO'B, McCaughey WTE. Pathological aspects of asbestosis. Postgrad Med J 1966;42:613-622.
443. Hasan FM, Nash G, Kazemi H. Asbestos exposure and related neoplasia. Am J Med 1978;65:649-654.
444. Kannerstein M, Churg 1. Pathology of carcinoma of the lung associated with asbestos exposure. Cancer 1972;30:14-21.
445. Finkelstein MM. Asbestosis in long-term employees of an Ontario asbestos-cement factory. Am Rev Respir Dis 1982;125:496-501.
446. Ives JC, Buffter PA, Greenberg D. Environmental associations and histopathologic patterns of carcinoma of the lung. Am Rev Respir Dis 1983;128:195-209.
447. Auerbach O, Garfinkel L, Parks VR, et al. Histologic type of lung cancer and asbestos exposure. Cancer 1984;54: 3017-3021.
448. Jacob G,Anspach M. Pulmonary neoplasia among Dresden asbestos workers. Ann NY Acad Sci 1965;132:536-548.
449. Hueper We. Occupational and environmental cancers of the respiratory system. New York: Springer-Verlag, 1966: 43.
450. Garland LH, Beier RI., Coulson W, Heald JH, Stein RL. The apparent sites of origin of carcinomas of the lung. Radiology 1962;78:1-11.
451. Lulu DJ, Lawson LL. Carcinoma of the lung. Arch Surg 1964;88:213-217.
452. Weiss W, Boucot KR. The Philadelphia pulmonary neoplasm research project: early roentgenographic appearance of bronchogenic carcinoma. Arch Intern Med 1974;134:306-311.
453. Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes: an epidemiologic survey. J Nat! Cancer Inst 1984;72:1271-1275.
454. Weiss W. Lobe of origin in the attribution of lung cancer to asbestos. Br J Ind Med 1988;45:544-547.
455. Babolini G, Blasi A. The pleural form of primary cancer of the lung. Dis Chest 1956;29:314-323.
456. Verga P, Botteri G. II carcinoma primitivo del pulmone. Cappelli, Bologna, 1931.
457. Liberti R, Stella G. II cancro primitivo del pulmone. Naples: EAT, 1949.
458. Sival L. La neoplasia primitiva polmonare: rapporti tra tipo istologico, sede e gli altri principali caratteri. Bioi Lat 1951;4:212.
459. Harwood TR, Gracey Dr, Yokoo H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol 1976;65:159-167.
460. Koss M, Travis W, Moran C, Hochholzer L. Pseudomesotheliomatous adenocarcinomas: a reappraisal. Semin Diagn PathoI1992;9:117-123.
461. Simonsen 1. Pseudomesotheliomatous carcinoma of the lung with asbestos exposure. Am 1 Forensic Med Pathol 1986;7:49-51.
462. Nishimoto Y, Ohno T, Saito K. Pseudomesotheliomatous carcinoma of the lung with histochemical and immunohistochemical study. Acta Pathol lpn 1983;33:415-423.
463. Lin 11, Tyy Seng CH, Tsung SH. Pseudomesotheliomatous carcinoma of the lung. South Med 11980;73:655-656.
464. Brganza 1M, Butler EB, Fox H, et al. Ectopic production of salivary type amylase by a pseudomesotheliomatous carcinoma ofthe lung. Cancer (Philadelphia) 1978;41:1522-1525.
465. Broghamer WL, Jr., Collins WM, Mojsenjenko IK. The cytohistopathology of a pseudomesotheliomatous carcinoma of the lung. Acta CytoI1978;22:239-242.
466. Dessy E, Pietra GG. Pseudomesotheliomatous carcinoma of the lung: an immunohistochemical and ultrastructural study of three cases. Cancer (Philadelphia) 1991;68:1747-1753.
467. Robb lA, Hammar SP, Yokoo H. Pseudo mesotheliomatous lung carcinoma: a rare asbestos-related malignancy readily separable from epithelial pleural mesothelioma. Lab Invest 1993;68:134A.
468. Hartmann CA, Schutze H. Mesothelioma-like tumors of the pleura: a review of 72 autopsy cases. J Can Res Clin Oncol1994;120:331-347.
469. Attanoos RL, Gibbs AR. "Pseudomesotheliomatous" carcinomas of the pleura: a lO-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff. Histopathology 2003;43:444-452.